$ALNY News

Alnylam Pharmaceuticals (NASDAQ:ALNY) Shows Accelerating Momentum as a High Growth Stock

Truist Securities Maintains Buy on Alnylam Pharmaceuticals, Lowers Price Target to $410

HC Wainwright & Co. Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $485

Is Alnylam Pharmaceuticals (ALNY) Cheap As Rival Trial Failure Shifts ATTR CM Expectations?

Is Rival ATTR-CM Trial Failure and New AI Deals Altering The Investment Case For Alnylam (ALNY)?

Alnylam (ALNY) Gets An Opening In ATTR CM As Rival Trial Fails

Morgan Stanley Maintains Equal-Weight on Alnylam Pharmaceuticals, Raises Price Target to $400

Alnylam Pharmaceuticals (ALNY) Stock Looks Rich On Earnings Yet Strong On Returns

Alnylam Pharmaceuticals (NASDAQ:ALNY): An Affordable Growth Stock with Explosive Momentum and a Reasonable Price

What Offers Alnylam Pharmaceuticals (ALNY) Sustained Long-Term Growth?

Komodo Expands Strategic Partnership with Alnylam Pharmaceuticals, Inc. (ALNY)

HC Wainwright & Co. Maintains Buy on Alnylam Pharmaceuticals, Lowers Price Target to $470

Alnylam Pharmaceuticals, Inc. (ALNY) Discusses ALN-6400 RNAi Therapy Targeting Plasminogen for Rare Bleeding Disorders Transcript

Alnylam Pharmaceuticals, Inc. (ALNY) Discusses ALN-6400 RNAi Therapy Targeting Plasminogen for Rare Bleeding Disorders - Slideshow

Komodo Expands Strategic Partnership With Alnylam to Scale AI-Powered Intelligence Platform

Komodo Health Expands Strategic Partnership With Alnylam Pharma To Scale Marmot, Komodo’s Analytics AI Platform, Across Key Enterprise Functions At Alnylam

Alnylam Pharmaceuticals, Inc. (ALNY) and GENESIS Pharma Expand Commercial Partnership

Alnylam Pharmaceuticals (ALNY), Inceptive Form $2B Partnership to Advance RNAi Drug Discovery

Alnylam (ALNY) Expands Its RNAi Therapeutics Reach Into Four More Nordic Countries

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) Passes the "Little Book" Test with Explosive Growth and Upward Momentum